Literature DB >> 8041771

A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases.

S Jia1, K McGinnis, W J VanDusen, C J Burke, A Kuo, P R Griffin, M K Sardana, K O Elliston, A M Stern, P A Friedman.   

Abstract

The alpha-ketoglutarate-dependent dioxygenase aspartyl (asparaginyl) beta-hydroxylase (EC 1.14.11.16) specifically hydroxylates one aspartic or asparagine residue in certain epidermal growth factor-like domains of a number of proteins. The expression in Escherichia coli, purification, characterization of a fully active catalytic domain, and evidence for the identification of an active-site region of this enzyme are described. Sequence alignment analyses among the vertebrate alpha-ketoglutarate-dependent dioxygenases and chemical modification studies were undertaken aimed at locating specific regions of 52-kDa recombinant aspartyl (asparaginyl) beta-hydroxylase involved in substrate binding and/or catalysis. Based upon these studies, an alignment of the C-terminal regions of prolyl and lysyl hydroxylase and of aspartyl (asparaginyl) beta-hydroxylase is proposed. When histidine-675, an invariant residue located in a region of homology within this alignment, was mutated to an alanine residue in aspartyl (asparaginyl) beta-hydroxylase (H675A), no enzymatic activity was detected. Chemical modification studies show that the wild-type protein is protected from iodo[14C]acetamide labeling by Fe2+/alpha-ketoglutarate whereas the H675A mutant protein is not, suggesting that this mutant does not bind Fe2+/alpha-ketoglutarate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041771      PMCID: PMC44372          DOI: 10.1073/pnas.91.15.7227

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Beta-hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C. Its role in Ca2+ binding and biological activity.

Authors:  A K Ohlin; G Landes; P Bourdon; C Oppenheimer; R Wydro; J Stenflo
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

Review 2.  Structure and function of epidermal growth factor-like regions in proteins.

Authors:  E Appella; I T Weber; F Blasi
Journal:  FEBS Lett       Date:  1988-04-11       Impact factor: 4.124

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.

Authors:  E Appella; E A Robinson; S J Ullrich; M P Stoppelli; A Corti; G Cassani; F Blasi
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

5.  A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation.

Authors:  K Suzuki; T Hayashi; J Nishioka; Y Kosaka; M Zushi; G Honda; S Yamamoto
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

6.  Inhibitors of 2-ketoglutarate-dependent dioxygenases block aspartyl beta-hydroxylation of recombinant human factor IX in several mammalian expression systems.

Authors:  C K Derian; W VanDusen; C T Przysiecki; P N Walsh; K L Berkner; R J Kaufman; P A Friedman
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

7.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase.

Authors:  J Stenflo; E Holme; S Lindstedt; N Chandramouli; L H Huang; J P Tam; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site.

Authors:  S Kurosawa; D J Stearns; K W Jackson; C T Esmon
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

10.  Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules.

Authors:  D D Monkovic; W J VanDusen; C J Petroski; V M Garsky; M K Sardana; P Zavodszky; A M Stern; P A Friedman
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

View more
  13 in total

1.  Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase.

Authors:  J Myllyharju; K I Kivirikko
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.

Authors:  Diana Lizarazo; Valerie Zabala; Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

3.  Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.

Authors:  Katsuya Nagaoka; Kousuke Ogawa; Chengcheng Ji; Kevin Y Cao; Xuewei Bai; Joud Mulla; Zhixiang Cheng; Jack R Wands; Chiung-Kuei Huang
Journal:  Dig Dis Sci       Date:  2020-05-22       Impact factor: 3.199

4.  Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.

Authors:  Takehiro Noda; Masafumi Shimoda; Vivian Ortiz; Alphonse E Sirica; Jack R Wands
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

5.  Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function.

Authors:  Elizabeth Silbermann; Peter Moskal; Nathaniel Bowling; Ming Tong; Suzanne M de la Monte
Journal:  Behav Brain Funct       Date:  2010-11-04       Impact factor: 3.759

6.  Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.

Authors:  L Lavaissiere; S Jia; M Nishiyama; S de la Monte; A M Stern; J R Wands; P A Friedman
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

7.  Revisiting the biosynthesis of dehydrophos reveals a tRNA-dependent pathway.

Authors:  Despina J Bougioukou; Subha Mukherjee; Wilfred A van der Donk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

8.  Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.

Authors:  Suzanne M de la Monte; Ming Tong; Rolf I Carlson; Jade J Carter; Lisa Longato; Elizabeth Silbermann; Jack R Wands
Journal:  Alcohol       Date:  2009-05       Impact factor: 2.405

9.  Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma.

Authors:  Martin Luu; Edmond Sabo; Suzanne M de la Monte; Wesley Greaves; JiYi Wang; Rosemarie Tavares; Lelia Simao; Jack R Wands; Murray B Resnick; LiJuan Wang
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

10.  Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells.

Authors:  Ming Tong; Jin-Song Gao; Diana Borgas; Suzanne M de la Monte
Journal:  Cell Biol (Henderson, NV)       Date:  2017-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.